Metrics as of 10/13/2026, 06:52 PM (Berlin time), refresh in progress.
Profound Medical Stock
Profound Medical Corp.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- Canada
- CEO
- Arun Swarup Menawat
- Employees
- 162
- Market cap
- $312 M
- IPO
- 10/07/2018
Profound Medical Corp., along with its subsidiaries, operates as a commercial-stage medical technology firm. The company specializes in creating magnetic resonance (MR) guided ablation therapies designed to address prostate conditions, uterine fibroids, and to provide palliative pain management. Its market reach…
Profound Medical stock: price history
1D
+0.7%
1W
+14.3%
1M
+18.1%
6M
+13.3%
YTD
-8.1%
1Y
+23.8%
2Y
-5.3%
5Y
-44.3%
10Y
–
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~60% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Profound Medical
Analyst assessment of Profound Medical
0
STRONG BUY
6
BUY
1
HOLD
0
SELL
0
STRONG SELL
7
TOTAL · Buy
As of: 07/01/2026
Profound Medical stock metrics
P/E
-7.18
P/B
5.09
EV/EBITDA
-6.65
RETURN ON EQUITY
-18.7%
NET MARGIN
-384.2%
DEBT/EQUITY
0.15
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
95.6%
FLOAT SHARES
34,732,967
AVG. DAILY VOLUME (30D)
13,500
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Profound Medical stock
What does Profound Medical do?
Profound Medical Corp. is a company in the Healthcare sector, Medical - Devices industry, headquartered in Canada.
The CEO is Arun Swarup Menawat, the company employs around 162 people.
The IPO was on 10/07/2018; the stock trades on TSX under the ticker PRN.TO.
What do analysts say about Profound Medical stock?
7 analysts rate the stock, the consensus is Buy (as of 07/01/2026).
This is an external assessment, not a statement by Market Jury.
When does Profound Medical report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 60% stronger than usual.
Does Profound Medical pay a dividend?
No, Profound Medical currently does not pay a dividend.
Which stocks are comparable to Profound Medical?
Comparable stocks include Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, Siemens Healthineers, DexCom and GE HealthCare Technologies.
How can I get Profound Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Profound Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.